Schizophrenia as a disorder of developmentally reduced synaptic connectivity

Archives of General Psychiatry

Volumn 57, Issue 7, 2000, Pages 637-648

  McGlashan, Thomas H ^a,b   Hoffman, Ralph E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale New Haven Psychiatric Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEVELOPMENT; HUMAN; NERVE DEGENERATION; NEURITE; SCHIZOPHRENIA; SHORT SURVEY; SYNAPSE;

EID: 0033936744     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.7.637     Document Type: Short Survey

References (264)

1. Kraepelin E. Dementia Praecox and Paraphrenia. Translated by RM Barclay. Huntington, NY: Robert E Krieger Publishing Co; 1971.
2. Huttenlocher PR. Synaptic density in the human frontal cortex: developmental changes and effects of aging. Brain Res. 1979;163:195-205.
3. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 1997;387:167-178.
4. Murphy KJ, Regan CM. Contributions of cell adhesion molecules to altered synaptic weightings during memory consolidation. Neurobiol Learn Mem. 1998;70:73-81.
5. Bock J, Braun K. Blockade of N-methyl-D-aspartate receptor activation suppresses learning-induced synaptic elimination. Proc Natl Acad Sci U S A. 1999;96:2485-2490.
6. Etienne P, Baudry M. Role of excitatory amino acid neurotransmission in synaptic plasticity and pathology: an integrative hypothesis concerning the pathogenesis and evolutionary advantages of schizophrenia-related genes. J Neural Transm. 1990;29(suppl):39-48.
7. Sestan N, Artevanis-Tsakonas S, Rakic P. Contact-dependent inhibition of cortical neurite growth mediated notch signaling. Science. 1999; 286:741-746.
8. Jernigan T, Tallal P. Late childhood changes in brain morphology observable with MRI. Dev Med Child Neurol. 1990;32:379-385.
9. Jernigan TL, Trauner DA, Hesselink JR, Tallal PA. Maturation of human cerebrum observed in vivo during adolescence. Brain. 1991;114:2037-2049.
10. Reiss A, Abrams M, Singer H, Ross J, Denckla M. Brain development, gender, and IQ in children: a volumetric imaging study. Brain. 1996; 119:1763-1774.
11. Giedd JN, Snell JW, Lange N, Rajapakse JC, Casey BJ, Kozuch PL, Vaituzis AC, Vauss YC, Hamburger SD, Kaysen D, Rapoport JL. Quantitative magnetic resonance imaging of human brain development: ages 4-18. Cereb Cortex. 1996;6: 551-560.
12. Sowell E, Thompson P, Holmes C, Jernigan TR, Barth R, Naravan S, Toga A. Statistical parametric mapping of structural brain changes between childhood and adolescence. Presented as poster 123.4 at: 28th Annual Meeting of the Society for Neurosciences; November 7-12, 1998; Los Angeles, Calif.
13. Sowell E, Jernigan T. Further MRI evidence of late brain maturation: limbic volume increases and changing asymmetries during childhood and adolescence. Dev Neuropsychol. In press.
14. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicolson R, Bedwell J, Lenane M, Zijdenbos A, Paus T, Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 1999;56:649-654.
15. Giedd J, Jeffries N, Nicolson R, Hamburger SD, Nelson J, Vaituzis AC, Lenane M, Rapoport JL. Differential progression of MRI ventricular and temporal lobe structure during adolescence for childhood onset schizophrenics. Biol Psychiatry. In press.
16. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Kim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994;51:874-887.
17. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 1983;17:319-334.
18. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000; 57:65-73.
19. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR, Hirsch SR. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446-453.
20. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TW. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry. 1999;46:616-626.
21. Black JE, Klintsova AY, Laddu A, Grossman A, Uranova NA, Kodish I, Greenough WT. Smaller, pathological layer V pyramidal neurons in prefrontal cortex with schizophrenia. Presented at: American Psychiatric Association Annual Meeting; May 19, 1999; Washington, DC.
22. Deakin JFW, Slater P, Simpson MDC, et al. Frontal cortical and left temporal glutaminergic deficiency in schizophrenia. J Neurochem, 1989; 52:1781-1786,
23. Sherman AD, Davidson AT, Baruah S, Hegwood TS, Waziri R. Evidences of glutamatergic deficiency in schizophrenia. Neurosci Lett. 1991; 121:77-90.
24. Sokolov BP, Tcherepanov A, Haroutunian V, Davis KL. Synaptic protein mRNA expression in schizophrenia. Presented at: American Psychiatric Association Annual Meeting; May 19,1999; Washington, DC.
25. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for "hypofrontality." Mol Psychiatry. 1999;4:39-45.
26. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A. 1996;93:14182-14187.
27. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 1997;54:943-952.
28. Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience. 1999;91:1247-1255.
29. Landen M, Davidsson P, Gottfries C, Grenfeldt B, Stridsberg M, Blennow K. Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia. Biol Psychiatry. 1999;46:1698-1702.
30. Pakkenberg B. Post-mortem study of chronic schizophrenic brains. Br J Psychiatry. 1987;151: 744-752.
31. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatr Res. 1995;59:81-96.
32. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52:805-818.
33. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215-224.
34. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry. 1999;45:17-25,
35. Harrison PJ. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain. 1999;122:593-624.
36. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V II, O'Leary DS, Ehrhardt JC, Yuh WTC Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging JAMA. 1994;272:1763-1769.
37. Gur RE, Mozley PD, Shtasel DL, Cannon TD, Gallacher F, Turetsky B, Grossman R, Gur RC. Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am J Psychiatry. 1994;151: 343-350.
38. Baare WFC, van Oel CJ, Hulshof Pol HE, Schnack H, Sitskoorn MM, Kahn RS. Genetics and intrauterine environment in schizophrenia: a twin study. Schizophr Res. 1999;36:189.
39. Ward K, Woods BT. The confounding effect of covariance for intracranial volume (ICV) on measurement of progressive brain volume (BV) loss in schizophrenia [abstract]. Schizophr Res. 1999; 36:214.
40. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatiy. 2000;157:16-25,
41. Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry. 1988;145:154-163.
42. Woods BT, Yurgelun-Todd D. Brain volume loss in schizophrenia: when does it occur and is it progressive? Schizophr Res. 1991;5:202-204.
43. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM, Henn FA, Anand AK. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry. 1991;29: 159-175.
44. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 1992;49:195-205.
45. Breier A, Buchanan RW, Elkashet A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 1992;49:921-926.
46. Harvey I, Ron MA, Du Boulay G, Wicks D, Lewis SW, Murray RM. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med. 1993;23:591-604.
47. Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 1994; 151:842-848.
48. Lim KO, Harris D, Beal M, Hoff AL, Minn K, Csernansky JG, Faustman WO, Marsh L, Sullivan EV, Pfefferbaum A. Gray matter deficits in young onset schizophrenia are independent of age of onset. Biol Psychiatry. 1996;40:4-13.
49. Lim KO, Tew W, Kushner M, Chow K, Matsumoto R, DeLisi LE. Cortical gray matter volume deficit in patients with first episode schizophrenia. Am J Psychiatry. 1996;153:1548-1553.
50. Gur RE, Turetsky BI, Bilker WB, Gur RC. Reduced gray matter volume in schizophrenia. Arch Gen Psychiatry. 1999;56:905-911.
51. Gur RE, Mozley D, Resnick SM, Shtasel D, Kohn M, Zimmerman R, Herman G, Atlas S, Grossman R, Erwin R, Gur RC. Magnetic resonance imaging in schizophrenia. Arch Gen Psychiatry. 1991;48:407-412.
52. Arango C, Vladar K, Bartko JJ, Buchanan RW. Brain abnormalities in schizophrenia: when do the changes take place? Schizophr Res. 1999; 36:189.
53. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer A, Sheton ME. MRI anatomy of schizophrenia. Biol Psychiatry. 1999;45:1099-1119.
54. Pearlson GD, Marsh L. Structual brain imaging schizophrenia: a selective review. Biol Psychiatry. 1999;46:627-649.
55. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? toward a unitary pathogenetic mechanism. Am J Psychiatry. 1998; 155:1661-1670.
56. Rapoport JL. Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, Nelson J. Hamburger S. Childhood-onset schizophrenia: progressive ventricular change during adolescence. Arch Gen Psychiatry. 1997;54:897-903.
57. Allen RM, Young SJ. Phencyclidine-induced psychosis. Am J Psychiatry. 1978;135:1081-1084.
58. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301-1308.
59. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbance in metachromatic leukodystrophy: insight into the neurobiology of psychosis. Arch Neurology. 1992;49:401-406.
60. Hoffman RE, McGlashan TH. Synaptic elimination, neurodevelopment and the mechanism of hallucinated "voices" in schizophrenia. Am J Psychiatry. 1997;154:1683-1689.
61. Hoffman RE. Verbal hallucinations and language production processes in schizophrenia. Behav Brain Sci. 1986;9:503-548.
62. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, Jones T, Frackowiak RSJ. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 1995;378:176-179.
63. David AS, Woodruff PW, Howard R, Mellers JD, Brammer M, Bullmore E, Wright I, Andrew C, Williams SC, Auditory hallucinations inhibit exogenous activation of auditory association cortex. Neuroreport. 1996;7:932-936.
64. Hoffman RE, Boutros NN, Berman RM, Roessler E, Krystal JH, Charney DS. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices." Biol Psychiatry 1999;46:130-132.
65. Hoffman RE, Rapoport J, Mazure CM, Quinlan DM. Schizophrenic patients reporting hallucinated "voices" demonstrate selective speech perception alterations. Am J Psychiatry. 1999;156: 393-399.
66. Hoffman RE, McGlashan TM. Using speech perception neural network simulations to explore normal neurodevelopment and hallucinated "voices" in schizophrenia. In: Reggia J, Ruppin E, Glanzman D, eds. Disorders of Brain, Behavior and Cognition: The Neurocomputational Perspective. Amsterdam, the Netherlands: Elsevier; 1999:18:311-325.
67. Hoffman RE, McGlashan TH. Parallel distributed processing and the emergence of schizophrenia symptoms. Schizophr Bull. 1993;19: 119-139.
68. Keshavan MS, Anderson S, Pettegrew J. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? the Feinberg hypothesis revisited. J Psychiatr Res. 1994;28: 239-265.
69. Anderson JE, O'Donnell BF, McCarley RW, Sheton ME. Progressive changes in schizophrenia: do they exist and what do they mean? Restor Neurol Neurosci. 1998;12:175-184.
70. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 1997;17:205-229.
71. Kraus J, Perkins DO, Lieberman JA. Pathophysiology of schizophrenia: neurodevelopmental and neurodegenerative processes. In: Miller TJ, Mednick SA, McGlashan TH, Libiger J, Johannessen JO, eds. Early Intervention in Psychotic Disorders. Amsterdam, the Netherlands: Kluwer Academic Publishers. In press.
72. Olney JW. Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry. 1989;26: 505-525.
73. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
74. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283:70-74.
75. Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry 1996;3:241-253.
76. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Neuroscience. 1995;3:89-97.
77. Friston KJ. Theoretical neurobiology and schizophrenia. Br Med Bull. 1996;52:644-655.
78. Andreasen NC. A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. Arch Gen Psychiatry. 1999;56:781-787.
79. McGlashan TH, Fention WS. The positive/ negative distinction in schizophrenia: review of natural history validators. Arch Gen Psychiatry. 1992;49:63-72.
80. Seeman P. Human brain dopamine receptors in children and aging adults. Synapse. 1987;1:399-404.
81. Seeman P. Pruning during development. Am J Psychiatry. 1999;156:168.
82. O'Donnel BF, Faux SF, McCarley RW, Kimble MO, Salisbury DF, Nestor PG, Kikinis R, Ferenc JA, Jolesz FA, Shenton ME. Increased rate of P300 latency prolongation with age in schizophrenia. Arch Gen Psychiatry. 1995;52:544-549.
83. Sachdev P, Brodaty H. Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia. Am J Psychiatry. 1999;156:1958-1967.
84. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm. 1986;65:303-326.
85. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? BMJ. 1987;295: 681-682.
86. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-667.
87. Jones GH, Lewis JE. Head size in dementia [letter], Br J Psychiatry. 1992;160:565.
88. Keshavan MS. Neurodevelopment and schizophrenia: quo vadis? In: Keshavan MS, Murry RM, eds. Neurodevelopment and Adult Psychopathology. Cambridge, England: Cambridge University Press; 1997:267-278.
89. Erlenmeyer-Kimling L, Squires-Wheeler E, Adamo U, Bassett AS, Cornblatt BA, Kestenbaum CJ, Rock D, Roberts SA, Gottesman II. The New York High-Risk Project: psychosis and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. Arch Gen Psychiatry. 1995;52:857-865.
90. Ingraham LJ, Kugelmass S, Frenkel MN, Mirsky AF. Twenty-five-year follow-up of the Israeli High Risk Study: current and lifetime psychopathology. Schizophr Bull. 1995;21:183-192.
91. Mirsky AF, Kugelmass S, Ingraham LJ, Frenkel E, Nathan M. Overview and summary: twenty-five-year follow-up of high-risk children. Schizophr Bull. 1996; 2:227-239.
92. Olin SS, Mednick SA. Risk factors of psychosis: identifying vulnerable populations premorbidity. Schizophr Bull. 1996;22:223-240.
93. Mednick SA, Machon RA, Hutunen MO, Bonnet D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988;45:189-192.
94. O'Callaghan E, Sham PC, Takei N, Murray G, Glover G, Hare EH, Murray RM. The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry. 1994;164:353-356.
95. Jones P, Pang D, Piriach S, Fine P. Prenatal viral infection and subsequent mental illness: a long term cohort study of 6152 subjects [abstract]. Schizophr Res. 1999;36:45.
96. Izumoto Y, Inoue S, Yasuda N. Schizophrenia and the influenza epidemics of 1957 in Japan. Biol Psychiatry. 1999;46:119-124.
97. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, Gorman JM. Schizophrenia after prenatal famine. Arch Gen Psychiatry. 1996; 53:25-31
98. Hoek HW, Brown AS, Dingemans A, HulshoffPol, Kahn RS, Susser E. Prenatal famine and schizophrenia spectrum disorders [abstract]. Schizophr Res. 1999;36:42.
99. Hollister JM, Laing P, Mednick SA. Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry. 1996;53: 19-23.
100. van OS J, Selten JP. Prenatal exposure to maternal stress and subsequent schizophrenia: the May 1940 invasion of the Netherlands. Br J Psychiatry. 1998;172:324-326.
101. Selten JP, van der Graaf Y, van Duursen R, Gispen-de Wied CC, Kahn RS. Psychotic illness after prenatal exposure to the 1953 Dutch flood disaster. Schizophr Res. 1999;35:243-245.
102. McNeil TF. Obstetric complications in schizophrenic patients. Schizophr Res 1991;5:89-101.
103. Rosso IM, Cannon TD, Huttunen T, Huttnunen M, Lonnqvist J, Gasperoni TL. Obstetric risk factors for early onset schizophrenia in a Finnish birth cohort [abstract]. Schizophr Res. 1999;36:53.
104. McNeil TF, Cantor-Graae E. Does preexisiting abnormality cause labor-delivery complications in fetuses who will develop schizophrenia? Schizophr Bull. 1999;25:425-435.
105. McNeil TF, Cantor-Graae E, Weinberger DR. The relationship of obstetric complications to brain structure size differences in monozygotic twin pairs discordant for schizophrenia [abstract]. Schizophr Res. 1999;36:51.
106. Cannon TD, vanErp TGM, Huttunen J, Lonnqvist SO, Valanne L, Poutanen VP. Standertskjold-Nordenstam CG. Perinatal hypoxia and regional brain morphology in schizophrenic patients, their siblings, and controls [abstract]. Schizophr Res. 1999;36:192.
107. Buka SL, Goldstein JM, Zornberg GL, Seidman LJ, Donatelli J, Denny LR, Tsuang MT. Interactive effects of parental schizophrenia and perinatal hypoxia on abnormal neurobehavioral development in childhood [abstract], Schizophr Res. 1999;36:37.
108. Seidman LJ, Goldstein JM, Buka SL, Zornberg GL, Denny L, Donatelli J, Burbridge J, Tsuang MT. Effects of genetic vulnerability and obstetric complications on cognitive functioning in offspring at high risk for psychosis [abstract]. Schizophr Res. 1999;36:54.
109. Zornberg GL, Buka SL, Tsuang MT. Fetal and neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year population-based follow-up study [abstract]. Schizophr Res. 1999;36:59.
110. Geddes JR, Verdoux H, Takei N, Lawrie M, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O'Callaghan E, Sötber G, Willinger U, Murray R. Schizophrenia and complications of pregnancy and labor: an individual patient data metaanalysis. Schizophr Bull. 1999;25:413-423.
111. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, Andersen PK. Melbye M. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med. 1999;340:603-608.
112. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 1996;92:217-231.
113. Roberts GW. Schizophrenia: a neuropathological perspective. Br J Psychiatry. 1991;158:8-17.
114. Jones P, Murray RM. The genetics of schizophrenia is the genetics of neurodevelopment. Br J Psychiatry. 1991;158:615-623.
115. Weinberger DR. From neuropathology to neurodevelopment. Lancet. 1995;346:552-557.
116. Grimes K, Walker EF. Childhood emotional expressions, educational attainment, and age at onset of illness in schizophrenia. J Abnorm Psychol. 1994;103:784-790.
117. Done D, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 1994;309:699-703.
118. Watt NF. Patterns of childhood social development in adult schizophrenics. Arch Gen Psychiatry. 1978;35:160-165.
119. Lewine RR, Watt NF, Prentky RA, Fryer JH. Childhood social competence in functionally disordered psychiatric patients and in normals. J Abnorm Psychol. 1980;89:132-138.
120. Olin SS, John RS, Mednick SA. Assessing the predictive value of teacher reports in a high risk sample for schizophrenia: an ROC analysis. Schizophr Res. 1995;16:53-66.
121. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 1994; 20:441-451.
122. Hans SL, Marcus J, Nuechterlein KH, Asarnow RF, Styr B, Auerbach JG. Neurobehavioral deficits at adolescence in children at risk for schizophrenia: The Jerusalem Infant Development Study. Arch Gen Psychiatry. 1999;56:741-748.
123. Bearden CE, Cannon TD, Hollister JM, Gasperoni TL, Hadley T. A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia [abstract]. Schizophr Res. 1999;36:37.
124. Gasperoni TL, Cannon TD, Bearden CE, Hollister JM, Rosso IM, HadleyT. Neuromotor abnormalities as precursors of schizophrenia: a prospective cohort study [abstract]. Schizophr Res. 1999;36:40.
125. Cannon M, Jones P, Huttunen MO, Tanskanen A. Huttunen T, Rabe-Hesketh S, Murray R. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry. 1999;56: 457-463.
126. Fish B. Neurobiological antecedents of schizophrenia in children. Arch Gen Psychiatry. 1997; 34:1297-1313.
127. Griffith JJ, Mednick SA, Schulsinger F. Diderichsen B. Verbal associative disturbances in children at high risk for schizophrenia. J Abnorm Psychol. 1980;89:125-131.
128. Marcus J, Hans SL, Auerbach JG, Auerbach AG. Children at risk for schizophrenia: The Jerusalem Infant Development Study, II: neurobehavioral deficits at school-age. Arch Gen Psychiatry. 1993;50:797-809.
129. Waddington JL, Lane A, Larkin C, O'Callaghan EO. The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biol Psychiatry. 1999;46:31-39.
130. Buckley PF. The clinical stigmata of aberrant neurodevelopment in schizophrenia. J Nerv Ment Dis. 1998;186:79-86.
131. David AS, Malmberg A, Lewis G, Brandt L, Allebeck B. Premorbid neuropsychological performance as a risk factor for schizophrenia: 13 year follow-up of 50,000 conscripts [abstract]. Schizophr Res. 1995;15:114.
132. Cornblatt B, Attention deficits as a marker of risk to schizophrenia. Presented at: International Congress on Schizophrenia Research: April 22,1999: Santa Fe, NM.
133. Bower EM, Shellhamer TA. School characteristics of male adolescents who later became schizophrenics. Am J Orthopsychiatry. 1960; 30:712-729.
134. Offord DR. School performance of adult schizophrenics, their siblings and age mates. Br J Psychiatry. 1974;125:12-19.
135. Aylward E, Walker E. Battes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophr Bull. 1984;10:430-459.
136. Crawford JR, Besson JAO, Bremner M, Ebmeier KP, Cochrane RHB, Kirkwood K. Estimation of premorbid intelligence in schizophrenia. Br J Psychiatry. 1992;161:69-74.
137. Kremen WS, Buka SL, Seidman LJ, IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. Am J Psychiatry. 1998;155:672-677.
138. Keith SJ, Regier DA, Rae RS. Schizophrenic disorders. In: Robins LN, Raegier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press; 1991:33-52,
139. Jones P, Rodgers B, Murray R, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994; 344:1398-1402.
140. Lane EA, Albee GW. On childhood intellectual decline of adult schizophrenics: a reassessment of an earlier study. J Abnorm Psychol. 1968;35: 747-753.
141. Offord DR, Cross LA. Adult schizophrenia with scholastic failure or low IQ in childhood. Arch Gen Psychiatry. 1971;24:431-436.
142. Kremen WS, Buka LJ, Seidman LJ, Goldstain JM, Koren D, Tsuang MT. Childhood IQ decline and adult psychotic symptoms in a community sample: a 19-year longitudinal study [abstract]. Schizophr Res. 1995;15:124.
143. Russel AJ, Munro JC, Jones PB, Hemsley DR, Murray RM. Schizophrenia and the myth of intellectual decline. Am J Psychiatry. 1997;154: 635-639.
144. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol Med. 1997; 27:1311-1323.
145. Isohanni I. Jarvelin MR, Nieminen P, Jones P, Rantakallio P, Jokelainen J, Isohanni M. School performance as a predictor of psychiatric hospitalization in adult life: a 28-year follow-up in the Northern Finland 1966 Birth Cohort. Psychol Med. 1998;28:967-974.
146. Cannon M, Jones P, Huttunen M, Tanskanen A, Huttunen T, Rabe-Hesketh S, Murray RM. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry. 1999;56: 457-463.
147. Andreasen NC, Hoenk PR. The predictive value of adjustment disorder: a follow-up study. Am J Psychiatry. 1982;139:584-590.
148. Erlenmeyer-Kimling L, Cornbiatt B. Behavioral risk factors in children of schizophrenic parents. J Autism Dev Disord. 1984;14:357-374.
149. Malmberg A, David A, Allebeck P, Lewis G. Premorbid adjustment and personality in schizophrenia: a review and historical cohort study. Br J Psychiatry. 1998;172:308-312.
150. Jones PB, van Os JJ. Predicting schizophrenia in teenagers: pessimistic results from the British 1946 birth cohort [abstract], Schizophr Res. 1998;29:11.
151. Huber G, Gross G, Schuttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull. 1980;6:592-605.
152. Gross G. The "basic" symptoms of schizophrenia. Br J Psychiatry. 1989;155(suppl 7):21-25.
153. Klosterkotter J, Ebel H, Schultze-Lutter F, Steinmeyer EM. Diagnostic validity of basic symptoms. Eur Arch Psychiatry Clin Neurosci. 1996; 246:147-154.
154. Hafner H, Riecher-Rossier A, Maurer K, Fatkenheuer B, Loffler W. First onset and early symptomatology of schizophrenia: a chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci. 1992;242:109-118.
155. Hafner H, Maurer K, Loffler W, Fatkenheur B, an der Heiden A, Riecher-Rossler A, Behrens S, Gattaz WF. The epidemiology of early schizophrenia: influence of age and gender on onset and early course. Br J Psychiatry. 1994;164 (suppl 23):29-38.
156. Hafner H, Nowotny B, Loffler W, an der Heiden W, Maurer K. When and how does schizophrenia produce social deficits? Eur Arch Psychiatry Clin Neurosci. 1995;246:17-28.
157. Hambrecht M, Hafner H, Loffler W. Beginning schizophrenia observed by significant others. Soc Psychiatry Psychiatry Epidemiol. 1994;29:53-60.
158. Hafner H, an der Heiden W. Epidemiology of schizophrenia. Can J Psychiatry. 1997;42:139-151.
159. Yung AR, McGorry PD. The prodromal phase of first episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370.
160. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283-303,
161. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8:470-484.
162. Haas GL, Sweeney JA. Premorbid and onset features of first episode schizophrenia. Schizophr Bull. 1992;18:373-386.
163. Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia, II: premorbid patterns by gender. Schizophr Bull. 1996;22:257-269.
164. Davidson M, Reichenberg MA, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999; 156:1328-1335.
165. Davidson M. Markers for schizophrenia in male adolescents. Presented at: World Psychiatry Association Meeting; August 8, 1999; Hamburg, Germany.
166. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr Bull. 1993;19:797-804.
167. Goldstein G, Allen DN, van Kammen DP. Individual differences in cognitive decline schizophrenia. Am J Psychiatry. 1998;155:1117-1118.
168. Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients Schizophi Bull. 1998;24:425-435.
169. Mohamed S, Paulsen JS, O'leary D, Arndt S, Andresen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry. 1999;56:749-754.
170. Gold S, Arndt S, Nopoulos P, O'leary DS, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry. 1999;156: 1342-1348.
171. Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am J Psychiatry. 1999;156:1336-1341.
172. Hyde TM, Nawroz S, Goldberg T, Bigelow LB, Strong D, Ostrem JL, Weinberger DR, Kleinman JE. Is there cognitive decline in schizophrenia? a cross-sectional study. Br J Psychiatry. 1994;164:494-500.
173. Aleman A, Hijman, deHaan EHF, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999;156:1358-1366.
174. DeGreef G, Bogerts B, Ashtari M, Lieberman J. Ventricular system morphology in first episode schizophrenia: a volumetric study of ventricular subdivisions on MRI [abstract]. Schizophr Res. 1990;3:18.
175. DeLisi LE, Hoff AL, Schwartz JE, Shield GW, Halthore SN, Gupta SM, Henn FA, Anand AK. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry. 1991;29: 159-175.
176. DeLisi LE, Stritzke P, Riordan H, Holan V, Boccio A, Kushner M, McClelland J, Van Eyl O, Anand A. The timing of brain morphology changes in schizophrenia and their relationship to clinical outcome. Biol Psychiatry. 1992;31:241-254.
177. Hemmingsen R, Madsen A, Karle A, Rubin P. Progressive cortical atrophy in first-episode schizophrenia [abstract]. Schizophr Res. 1999;36:200.
178. Zipursky RB, Lambe E, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry. 1998; 55:540-546.
179. Nopoulos P, Torres I, Flaum M, Andreasen NC, Ehrardt JC, Yum WTC. Brain morphology in first episode schizophrenia. Am J Psychiatry. 1995; 152:1721-1729.
180. Hirayasu Y, Sheton ME, Salisbury DR, Dickey CD, Fischer IA, Mazzoni P. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry 1998a;155: 1384-1391.
181. McGlashan TH. Schizophrenia: psychosocial therapies and the role of psychosocial factors in its etiology and pathogenesis. In: Frances AJ, Hales RE, eds. The American Psychiatric Association Annual Review. Washington, DC: American Psychiatric Press; 1986:96-111.
182. McGlashan TH. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull. 1988;14:515-542.
183. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with mental illness, I: methodology, study sample, and overall status 32 years later. Am J Psychiatry. 1987;144:718-726.
184. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with mental illness, II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry. 1987;144:727-735.
185. Carone BJ, Harrow M, Westermeyer JF. Posthospital course and outcome in schizophrenia. Arch Gen Psychiatry. 1991;48:247-253.
186. Carpenter WT, Strauss JS. The prediction of outcome in schizophrenia, IV: eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis. 1991;179:517-525.
187. DeSisto MJ, Harding CM, McCormick RV, Ashikaga T, Brooks GW. The Maine and Vermont three-decade studies of serious mental illness, I: matched comparison of cross-sectional outcome. Br J Psychiatry. 1995;167:331-338.
188. DeSisto MJ, Harding CM, McCormick RV, Ashikaga T, Brooks GW. The Maine and Vermont three-decade studies of serious mental illness, II: longitudinal course comparisons. Br J Psychiatry. 1995;167:338-342.
189. Davidson L, McGlashan TH. The varied outcomes of schizophrenia. Can J Psychiatry. 1997; 42:34-43.
190. Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, Davidson M, Davis KL. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry. 1999;45:32-40.
191. Barak Y, Swartz M, Davidson M. Dementia in elderly schizophrenic patients: reviewing the reviews. Int Rev Psychiatry. 1997;9:459-463.
192. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry. 1993; 33:255-260.
193. Friedman JI, Harvey PD, Kemether E, Byne W, Davis KL. Cognitive and functional changes with aging in schizophrenia. Biol Psychiatry 1999; 46:921-928.
194. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes, I: longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Arch Gen Psychiatry. 1991;48: 969-977.
195. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes, II: positive and negative symptoms and long-term course. Arch Gen Psychiatry. 1991;48:978-986.
196. McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr Bull. 1993;19:71-84.
197. Leiberman JA, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, Woerner M. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology. 1996;14 (suppl):13S-21S.
198. Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P. Long-term course of hospitalization for schizophrenia, part I: risk for hospitalization. Schizophr Bull. 1992;18:217-228.
199. Eaton WW, Bilker W, Haro JM, Herrman H, Mortensen PB, Freeman H. Long-term course of hospitalization for schizophrenia, part II: change with passage of time. Schizophr Bull. 1992;18: 229-241.
200. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand. 1999;100:119-125.
201. DeGreef G, Ashtari M, Wu H, Borenstein M, Geisler S, Lieberman J. Follow-up MRI study in first episode schizophrenia. Schizophr Res. 1991;5: 204-206.
202. Sponheim SR, Iocono WG, Beiser M. Stability of ventricular size after the onset of psychosis in schizophrenia. Psychiatry Res Neuroimaging. 1991;40:21-29.
203. DeGreef G. Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir JMJ, Lieberman JA. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry. 1992;49: 531-537.
204. Jaskiw GE, Juliano DM, Goldberg TE, Hertzman M, Urowhamell E, Weinberger DR. Cerebral ventricular enlargement in schizophreniform disorder does not progress: a seven-year follow-up study. Schizophr Res. 1994;14:23-28.
205. Vita A, Giobbio GM, Dieci M, Garbarini M, Morganti C, Comazzi M, Inverniizzi G, Stability of cerebroventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol Psychiatry. 1994;35:960-962.
206. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Longitudinal analysis of MRI brain volumes in schizophrenia. Schizophr Res. 1997; 24:152.
207. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, Lee G, Shadlock K, Smith AM, Grimson R. A prospective follow-up study of brain morphology and cognitive in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry. 1995;38:349-360.
208. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129-140.
209. Davis KL, Buchsbaum MS, Shihabuddin L. Spiegel-Cohen J, Metzger M, Frecska E, Keefe RS, Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry. 1998; 43:783-793.
210. Kemali D, Maj M, Galderisi S, Milici N, Salvati A. Ventricle to brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry 1989; 26:753-756.
211. Woods BT, Yurgelun-Todd D, Berres FM, Frankenburg FR, Pope HG, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry. 1990; 27:341-352.
212. Hirayasu Y, Sheton ME, Salisbury DR, Dickey CD, Fischer IA, Kisler T, Kwon JS. Superior temporal gyrus changes over time in first-episode schizophrenia [abstract]. Biol Psychiatry. 1998; 43:116S.
213. Nair TR, Christensen JD, Kingsbury SJ, Kumar NG, Terry WM, Garver DL. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res 1997;74:141-150.
214. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55:145-152
215. Garver DL. The etiologic heterogeneity of schizophrenia. Harvard Rev Psychiatry. 1997;4:317-327.
216. Pettegrew JW, Keshevan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug naive schizophrenics. Arch Gen Psychiatry. 1991;48:563-568.
217. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett J, Malla A, Thompson RT. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry. 1995;52:399-406.
218. Knoll JL, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B. Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull. 1998;24:365-379.
219. Bedwell JS, Keller B, Smith AK, Hamburger S, Kumra S, Rapoport JL. Why does postpsychotic IQ decline in childhood-onset schizophrenia? Am J Psychiatry. 1999;156:1996-1997.
220. Bardenstein KK, McGlashan TH. Gender differences in affective, schizoaffective and schizophrenic disorders: a review. Schizophr Res. 1990; 3:159-172.
221. McGlashan TH, Bardenstein KK. Gender differences in affective, schizoaffective and schizophrenic disorders. Schizophr Bull. 1990;16:319-329.
222. Goldstein JM, Tsuang MT. Gender and schizophrenia. Schizophr Bull. 1990;16:179-194.
223. Loranger AW. Sex differences in age of onset of schizophrenia. Arch Gen Psychiatry. 1984;41: 157-161.
224. Hafner H, Behrens S, DeVry J, Gattaz WF. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic transmission: evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci. 1991; 241:65-68.
225. Riecher-Rossler A, Hafner H, Dutsch-Trobel A, Oster M, Stumbaum M, van Gülick-Bailer M. Further evidence for a specific role of estradiol in schizophrenia. Biol Psychiatry. 1994;36:492-495.
226. Seeman MV. Interaction of sex, age, and neuroleptic dose. Compr Psychiatry. 1983;24:125-128.
227. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull. 1990;16:185-194.
228. Maclusky NJ, Naftolin F. Sexual differentiation of the central nervous system. Science. 1981; 211:1294-1302.
229. MacLusky NJ, Clark AS, Naftolin F, Goldman-Rakic PS. Estrogen formation in the mammalian brain: possible role of aromatase in sexual differentiation of the hippocampus and neocortex. Steroids. 1987;50:459-474.
230. McEwen BS. Neural gonadal steroid actions. Science. 1981;211:1303-1311.
231. McGlone J. Sex differences in human brain asymmetry: a critical survey. In: The Behavioral and Brain Sciences. Cambridge, England: Cambridge Univeristy Press; 1980:215-263.
232. Puzzo-Miller LD. Inoue T, Murphy DD. Estradiol increases spine density and NMDA-dependent Ca2+ transients in spines of CA1 pyramidal neurons from hippocampal slices. J Neurophysiol. 1999;81:1404-1411.
233. Desmond NL, Levy WB. Ovarian steroidal control of connectivity in the female hippocampus: an overview of recent experimental findings and speculations on its functional consequences. Hippocampus. 1997;7:239-245,
234. Naftolin F, Garcia-Segura LM, Keefe D, Leranth C, Maclusky NJ, Brawer JR. Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus. Biol Reprod. 1990;42:21-28.
235. Munoz-Cueto A, Garcia-Segura M, Ruiz-Marcos A. Developmental sex differences and effect of ovariectomy on the number of cortical pyramidal cell dendritic spines. Brain Res. 1990; 515:64-68.
236. Woolley CS, Wenzel HJ, Schwartzkroin PA. Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Comp Neurol. 1996;373: 108-117.
237. Asarnow J. Annotation: childhood onset schizophrenia. J Child Psychol Psychiatry. 1994;35: 1345-1371.
238. Remschmid HE, Schulz E, Martin M, Warnke A, Trott GE, Childhood-onset schizophrenia: history of the concept and recent studies. Schizophr Bull. 1994;20:727-745.
239. Stefanis N, Frangou S, Yakeley J, Sharma T, O'Connell P, Morgan K, Sigmudsson T, Taylor M, Murray R. Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol Psychiatry. 1999;46:697-702.
240. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry. 1999;46: 899-907.
241. Hoffman RE, McGlashan TH. Reduced corticocortical connectivity can induce speech perception pathology and hallucinated "voices." Schizophr Res. 1998;30:137-141.
242. Casey BJ. Maturation in brain activation. Am J Psychiatry. 1999;156:504.
243. Chechik C, Meilijson I, Ruppin E. Synaptic pruning in development: a computational account. Neural Comput. 1998;10:1759-1777.
244. Changuex JP, Danchin A. Selective stabilisation of developing synapses as a mechanism for the specification of neuronal networks. Nature. 1976; 264:705-712.
245. Bock J, Braun K. Filial imprinting in domestic chicks is associated with spine pruning in the associative area, dorsocaudal neostriatum. Eur J Neurosci. 1999;11:2566-2570.
246. Buchel C, Coull JT, Friston KJ. The predictive value of changes in effective connectivity for human learning. Science. 1999;283:1538-1541.
247. Bock J, Braun K. Differential emotional experience leads to pruning of dendritic spines in the forebrain of domestic chicks. Neural Plast. 1998; 6:17-27.
248. Carlson M, Earls F, Todd RD. The importance of regressive changes in the development of the nervous system: towards a neurobiological theory of child development. Psychiatr Dev. 1988;1:1-22.
249. Karlsson J. Inheritance and Creative Intelligence. Chicago, III: Nelson-Hall; 1978.
250. Karlsson J. Family transmission of schizophrenia: a review and synopsis. Br J Psychiatry. 1982; 140:600-606.
251. Lange-Eichbaum W. Genius and insanity. In: Lange-Eichbaum W, ed. The Problem of Genius. New York, NY: MacMillan; 1932:102-141.
252. Anthony EJ, Cohler BJ, eds. The Invulnerable Child. New York, NY: The Guilford Press; 1987.
253. Jablensky A, Sartorius N, Ernberg G, Anker M, Kortn A, Cooper JE, Day R, Bertelsen A. Schizophrenia: manifestations, incidence and course in ditferent cultures: a World Health Organization ten-country study. Psychol Med, Monograph Suppl 20. Cambridge, England: Cambridge University Press; 1992.
254. Book JA. Schizophrenia as a gene mutation. Acta Genet. 1953;4:133-139.
255. MacSorley K. An investigation into the fertility rates of mentally ill patients. Ann Hum Genet Lond. 1964;27:247-256.
256. Haverkamp F, Propping P, Hilger T. Is there an increase of reproductive rates in schizophrenics? I: critical review of the literature. Arch Psychiatr Nevernkr. 1982;232:439-450.
257. Crow TJ. A Darwinian approach to the origins of psychosis. Br J Psychiatry. 1995;167:12-25.
258. Neissen U, ed. The Rising Curve: Long-Term Gains in IO and Related Measures. Washington, DC: American Psychological Association; 1998.
259. Pearlson GD, Marsh L. Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry. 1999;46:627-649.
260. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 1999;56:367-374.
261. Ilmoniemi RJ, Virtanen J, Ruohonen J, Karhu J, Aronen HJ, Naatanen R, Katila T. Neuronal responses to magnetic stimulation reveal cortical reactivity and connectivity. Neuroreport. 1997; 8:3537-3540.
262. Paus T, Jech R, Thompson CJ. Comeau R, Peters T, Evans AC. Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. J Neurosci. 1997;17:3178-3184
263. Sugarhara M, Shiraishi H, Synaptic density of the prefrontal cortex regulated by dopamine instead of serotonin in rats. Brain Res. 1998;814: 143-156.
264. Sugarhara M, Shiraishi H. Dopamine D1 and D2 receptor agents and their interaction influence the synaptic density of the rat pretrontal cortex. Neurosci Lett. 1999;259:141-144.